Adrenergic receptors are a class of G protein-coupled receptors that are targets of the catecholamines, especially norepinephrine and epinephrine.These receptors are found on numerous cells, and when a catecholamine binds to one of these receptors, the sympathetic nervous system is typically stimulated. The fight-or-flight response, which entails dilating the pupils of the eyes, mobilizing energy, and rerouting blood flow away from skeletal muscle to non-essential organs, is controlled by the sympathetic nervous system.There are numerous subtypes of the two main groups of adrenergic receptors, and. The receptor subtypes 1 and 2 exist. There are three subtypes of receptors: 1, 2, and 3. They are all associated with Gs proteins, which are associated with adenylate cyclase. Thus, antagonist binding increases the level of the second messenger cAMP inside of the cell. The cAMP-dependent protein kinase (PKA), one of cAMP's downstream effectors, mediates some intracellular processes after hormone binding.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V101112 | (-)-Isoproterenol hydrochloride | 5984-95-2 | (-)-Isoproterenol (L-isoproterenol; Proternol L) hydrochloride is a β-adrenergic receptor agonist. |
|
V116575 | (1R,2S)-Dihydrobupropion | 292055-72-2 | (1R,2S)-dihydrobupropion is a norepinephrine-dopamine reuptake inhibitor and one of the active metabolites of bupropion. |
|
V112149 | (2S,3S)-Zenidolol hydrochloride | 1236034-74-4 | (2S,3S)-Zenidolol ((2S,3S)-ICI-118551) hydrochloride is a β2-adrenergic receptor (β2AR) antagonist with a pKi value of 7.51 for β1AR and 9.27 for β2AR. |
|
V87631 | (Rac)-Nebivolol-d2,15N | (Rac)-Nebivolol-d2,15N is 15N and deuterium labeled (Rac)-Nebivolol. | |
|
V84080 | (Rac)-Nebivolol-d4 hydrochloride ((Rac)-R 065824-d4 hydrochloride) | 2701283-32-9 | |
|
V101375 | (S)-Atenolol | 93379-54-5 | (S)-Atenolol is a potent β-adrenergic receptor blocker. |
|
V113025 | (S)-Doxazosin | 104874-86-4 | (S)-Doxazosin is a long-acting selective α1-adrenergic receptor antagonist. |
|
V110173 | (S)-Trimetoquinol hydrochloride | 18559-59-6 | (S)-Trimethylquinolone hydrochloride (compound 1) is a potent, nonselective, nonclassical β-adrenergic agonist and a nonprostaglandin A2/prostaglandin H2 antagonist. |
|
V102882 | (±)-4-Hydroxy propranolol β-D-glucuronide | 94731-13-2 | (±)-4-Hydroxypropranolol β-D-glucuronide is a metabolite of the β-adrenergic receptor antagonist 4-hydroxypropranolol. |
|
V102678 | (±)-Penbutolol | 36507-48-9 | (±)-Penbutolol ((Rac)-Penbutolol) is the racemic form of penbutolol. |
|
V115621 | (±)-WB 4101 | 613-67-2 | (±)-WB 4101 is a highly selective α1-adrenergic receptor inhibitor. |
|
V107164 | 2,3-MDMA hydrochloride | 168968-01-2 | 2,3-MDMA hydrochloride is a norepinephrine transporter and serotonin transporter inhibitor with IC50 values of 6.2 μM and 82 μM, respectively. |
|
V92173 | 3,4-Dihydro-6,7-isoquinolinediol | 4602-83-9 | 3,4-Dihydro-6,7-isoquinolinediol (compound 7) is a β2-AR agonist with EC50 of 106.9 μM in CH-K1/GA1S cells. |
|
V101068 | 4-Hydroxy nebivolol hydrochloride | 2717115-85-8 | 4-Hydroxynebivolol (4-OH nebivolol) hydrochloride is the active β-blocking hydrolytic metabolite of nebivolol. |
|
V86520 | 5,6-Epoxyeicosatrienoic acid | 87173-80-6 | 5,6-Epoxyeicosatrienoic acid (5,6-EET; (±)5,6-EpETrE) is a fully racemic form of the enantiomer biosynthesized from arachidonic acid by cytochrome P450 enzymes. |
|
V102915 | 5-Hydroxy propranolol | 81907-82-6 | 5-Hydroxypropranolol is a metabolite of propranolol and can be used to study the β-adrenergic receptor blocking effect. |
|
V114283 | A 131701 | 181490-18-6 | A131701 is a selective α1a receptor (human α1a receptor Ki value: 0.22 nM) and α1d adrenergic receptor antagonist. |
|
V102470 | A 80426 mesylate | 152148-64-6 | A 80426 mesylate is an alpha2-adrenergic receptor antagonist. |
|
V110620 | Acepromazine-d6 hydrochloride | 1173022-70-2 | Acepromazine-d6 hydrochloride is a deuterated acepromazine hydrochloride. |
|
V98017 | Aclidinium | 727649-81-2 | Aclidinium bromide is a long-acting muscarinic antagonist and long-acting β2-adrenergic receptor (β2-AR) agonist with bronchodilatory effects. |